DaVita DVA Stock
DaVita Price Chart
DaVita DVA Financial and Trading Overview
| DaVita stock price | 231.61 USD |
| Previous Close | 232.8 USD |
| Open | 233.35 USD |
| Bid | 234.98 USD x 10000 |
| Ask | 235.58 USD x 10000 |
| Day's Range | 233.31 - 239.44 USD |
| 52 Week Range | 101 - 239.64 USD |
| Volume | 464.75K USD |
| Avg. Volume | 873.77K USD |
| Market Cap | 15.12B USD |
| Beta (5Y Monthly) | 0.882 |
| PE Ratio (TTM) | 22.414843 |
| EPS (TTM) | 10.39 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 202.14 USD |
DVA Valuation Measures
| Enterprise Value | 29.48B USD |
| Trailing P/E | 22.414843 |
| Forward P/E | 13.67927 |
| PEG Ratio (5 yr expected) | 0.72 |
| Price/Sales (ttm) | 1.0929242 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.131 |
| Enterprise Value/EBITDA | 10.557 |
Trading Information
DaVita Stock Price History
| Beta (5Y Monthly) | 0.882 |
| 52-Week Change | 62.33% |
| S&P500 52-Week Change | 20.84% |
| 52 Week High | 239.64 USD |
| 52 Week Low | 101 USD |
| 50-Day Moving Average | 200.93 USD |
| 200-Day Moving Average | 148.69 USD |
DVA Share Statistics
| Avg. Volume (3 month) | 873.77K USD |
| Avg. Daily Volume (10-Days) | 922.15K USD |
| Shares Outstanding | 64.19M |
| Float | 34.18M |
| Short Ratio | 5.4 |
| % Held by Insiders | 46.89% |
| % Held by Institutions | 52.80% |
| Shares Short | 4.54M |
| Short % of Float | 13.83% |
| Short % of Shares Outstanding | 7.07% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 5.64% |
| Operating Margin (ttm) | 13.86% |
| Gross Margin | 32.45% |
| EBITDA Margin | 20.18% |
Management Effectiveness
| Return on Assets (ttm) | 7.49% |
| Return on Equity (ttm) | 80.98% |
Income Statement
| Revenue (ttm) | 13.84B USD |
| Revenue Per Share (ttm) | 194.22 USD |
| Quarterly Revenue Growth (yoy) | 6.00% |
| Gross Profit (ttm) | 4.49B USD |
| EBITDA | 2.79B USD |
| Net Income Avi to Common (ttm) | 756.42M USD |
| Diluted EPS (ttm) | 10.51 |
| Quarterly Earnings Growth (yoy) | 21.19% |
Balance Sheet
| Total Cash (mrq) | 666.55M USD |
| Total Cash Per Share (mrq) | 10.38 USD |
| Total Debt (mrq) | 13.22B USD |
| Total Debt/Equity (mrq) | 1261.33 USD |
| Current Ratio (mrq) | 1.417 |
| Book Value Per Share (mrq) | -11.415 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.03B USD |
| Levered Free Cash Flow (ttm) | 999.66M USD |
Profile of DaVita
| Country | United States |
| State | CO |
| City | Denver |
| Address | 2000 16th Street |
| ZIP | 80202 |
| Phone | 720 631 2100 |
| Website | https://www.davita.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 78000 |
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Q&A For DaVita Stock
What is a current DVA stock price?
DaVita DVA stock price today per share is 231.61 USD.
How to purchase DaVita stock?
You can buy DVA shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DaVita?
The stock symbol or ticker of DaVita is DVA.
Which industry does the DaVita company belong to?
The DaVita industry is Medical Care Facilities.
How many shares does DaVita have in circulation?
The max supply of DaVita shares is 64.19M.
What is DaVita Price to Earnings Ratio (PE Ratio)?
DaVita PE Ratio is 22.29162600 now.
What was DaVita earnings per share over the trailing 12 months (TTM)?
DaVita EPS is 10.39 USD over the trailing 12 months.
Which sector does the DaVita company belong to?
The DaVita sector is Healthcare.
DaVita DVA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P 500 INDEX
SPX
US
|
7572.4 USD — |
+0.38
|
3.12B USD — | 7526.95 USD — | 7581.5 USD — | — - | 3.12B USD — |
|
S&P 500 (Yahoo.com)
GSPC
US
|
7572.4 USD — |
+0.38
|
3.09B USD — | 7526.95 USD — | 7581.5 USD — | — - | 3.09B USD — |
|
NYSE Composite Index
NYA
US
|
23872.53 USD — |
+0.11
|
— — | — — | — — | — - | — — |
|
US Tech CRD Global Sustainabilit
NQCRD
US
|
1735.62 USD — |
0
|
— — | 1715.94 USD — | 1757.95 USD — | — - | — — |
|
US Tech Global BuyBack Achievers
DRBG
US
|
3023.61 USD — |
+0.75
|
— — | 3000.97 USD — | 3030.04 USD — | — - | — — |
|
US Tech DM Ex Japan Large Mid Ca
NQDMXJPLMAUD
US
|
2100.38 AUD 1467.26 USD |
<0.01
|
— — | 2100.38 AUD 1467.26 USD | 2100.38 AUD 1467.26 USD | — - | — — |
- {{ link.label }} {{link}}